SPECIFIC APPLICATIONS OF CYTOKERATIN ANTIBODIES

DIRECTLY LABELED CYTOKERATIN ANTIBODIES FOR APPLICATION IN FLOW CYTOMETRY

To those investigators and clinicians dealing with DNA flow cytometric analysis of patient tumors it may be a daily experience that such analyses of carcinomas are in many instances disturbed or made impossible by the presence of stromal and inflammatory cells in the tumor cell suspensions. The variability of these admixtures makes it often difficult to determine the proliferation capacity or even to estimate the ploidy of a certain tumor. These parameters have, however, been shown to be of prognostic significance for several types of tumors.

In order to exclude the non-epithelial cell types from such analyses we have developed a two-parameter method using cytokeratin antibodies. For this purpose single cell suspensions from fresh frozen tissues are fixed in 70 % ethanol and stained with FITC-conjugated cytokeratin antibodies. Thereafter DNA is labelled with propidium iodide. The epithelial (cytokeratin positive) cells can now be separated from non-epithelial  (cytokeratin negative) cells in a two-parameter analysis.

Recently we have developed a procedure to prepare and analyse paraffin embedded tissues in such a two parameter cytokeratin/DNA flow cytometric assay.

Flow cytometric analysis of a suspension from an adenocarcinoma of the breast isolated from paraffin blocks and labeled with FITC- conjugated monoclonal antibody RCK108 (b) or with  RCK108 in an indirect immunofluorescence assay (d). Figures a and c are negative controls for b and d, respectively.